Ann: Immutep presentation for Jefferies Healthcare Conference, page-130

original post by Vivo. HC playing up again...

"I respectfully disagree. Immutep is a global biotech. If what you say is true then biotech companies wouldn’t be based here. There is no way any company would pass up a three times valuation increase simply by changing domicile.A successful program and intellectual property has the same value in the market no matter where it is developed .As a case in point, the serious rise in Imugene’s valuation shows that where you are based or listed doesn’t matter"

True and the partnership network developed by MV, pharma testing distribution and manufacturing...
new paradigm.. both on "B2B" also "crowd funding" is bingn achieved through different channels now... think the reddit crowd + gamestop + the boardroom. GameStop was able to secure funding to restructure the business through short term price manipulation by retail traders... the bankksters are worried... the markets may well be a democratic voting machine once again...(gamestop only mentioned for illustration purposes).

Elon has shown the power of the crowd. It has protected Tesla from major short interest...